NextCure, Inc.

NXTC · Nasdaq · SIC 2834: Pharmaceutical Preparations
107
SEC Filings

Business Summary

PART I Overview We are a clinical-stage biopharmaceutical company that is focused on advancing innovative medicines that treat cancer patients that do not respond to, or that have disease progression on, current therapies, through the use of targeted therapies, including antibody-drug conjugates (ADCs). An ADC consists of a monoclonal antibody conjugated to a cytotoxic drug via a chemical linker. We focus on advancing therapies that leverage our core strengths in understanding biological pathway...

Next Earnings

Q2 FY2026 — expected 2026-08-13

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionNXTCdiscussed_in_filing Cybersecurity
topic_mentionNXTCdiscussed_in_filing Trusted Computing
topic_mentionNXTCdiscussed_in_filing Blockchain & Crypto
topic_mentionNXTCdiscussed_in_filing Regulation
topic_mentionNXTCdiscussed_in_filing Healthcare & Bio
topic_mentionNXTCdiscussed_in_filing Platform & Ecosystem
topic_mentionNXTCdiscussed_in_filing Cybersecurity
topic_mentionNXTCdiscussed_in_filing Trusted Computing
topic_mentionNXTCdiscussed_in_filing Blockchain & Crypto
topic_mentionNXTCdiscussed_in_filing Regulation
topic_mentionNXTCdiscussed_in_filing Healthcare & Bio
topic_mentionNXTCdiscussed_in_filing Platform & Ecosystem
topic_mentionNXTCdiscussed_in_filing Cybersecurity
topic_mentionNXTCdiscussed_in_filing Trusted Computing
topic_mentionNXTCdiscussed_in_filing Blockchain & Crypto
topic_mentionNXTCdiscussed_in_filing Regulation
topic_mentionNXTCdiscussed_in_filing Healthcare & Bio
topic_mentionNXTCdiscussed_in_filing Platform & Ecosystem
topic_mentionNXTCdiscussed_in_filing Cybersecurity
topic_mentionNXTCdiscussed_in_filing Trusted Computing

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-052025-12-310001104659-26-024137EDGAR79K words
2025-03-062024-12-310001558370-25-002402EDGAR—
2024-03-212023-12-310001558370-24-003672EDGAR—
2023-03-022022-12-310001558370-23-002698EDGAR—
2022-03-032021-12-310001558370-22-002824EDGAR—
2021-03-042020-12-310001558370-21-002384EDGAR—
2020-03-122019-12-310001558370-20-002566EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-052025-09-300001104659-25-107036EDGAR18K words
2025-08-072025-06-300001558370-25-010782EDGAR—
2025-05-012025-03-310001558370-25-006111EDGAR—
2024-11-072024-09-300001558370-24-014869EDGAR—
2024-08-012024-06-300001558370-24-010605EDGAR—
2024-05-022024-03-310001558370-24-006551EDGAR—
2023-11-022023-09-300001558370-23-017429EDGAR—
2023-08-032023-06-300001558370-23-013250EDGAR—
2023-05-042023-03-310001558370-23-008131EDGAR—
2022-11-032022-09-300001558370-22-016275EDGAR—
2022-08-042022-06-300001558370-22-012232EDGAR—
2022-05-052022-03-310001558370-22-007439EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-050001104659-26-024121EDGAR2K words
2026-01-230001104659-26-006021EDGAR—
2025-12-190001104659-25-123305EDGAR—
2025-11-170001104659-25-112975EDGAR—
2025-11-050001104659-25-107008EDGAR—
2025-08-250001558370-25-011752EDGAR—
2025-08-070001558370-25-010774EDGAR—
2025-07-140001558370-25-009214EDGAR—
2025-07-100001558370-25-009163EDGAR—
2025-06-230001558370-25-008789EDGAR—

107 total filings indexed. 78 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001661059
TickerNXTC
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 6fda3fe56384c31702bfc0e26747d7e4a3dcd5baeb39c4456ab21220f1588c49
parent: eafdcb74c58b2cbcfaad839eafd68c8a0d237db756f657e0b988c4423504c070
content hash: 51d10982278303104a6a42ade594e3693cebb4c3051d07c1bfdc5beff64bec30
signed: 2026-04-13T04:46:39.345Z
sources: 19 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf